Table 5.
Measures | TIBP+PAa, d (95% CI) | TIBPb, d (95% CI) | WLc, d (95% CI) | TIBP+PA versus TIBP, d (95% CI) | TIBP+PA versus WL, d (95% CI) | TIBP versus WL, d (95% CI) | ||||||||
|
Pre-post | Pre-post | Pre-post | Post-Td | Post-T | Post-T | ||||||||
Primary outcomes | ||||||||||||||
|
BDI-IIe | 1.42 (1.09 to 1.76) | 1.19 (0.90 to 1.48) | 0.02 (−0.13 to 0.16) | −0.10 (−0.51 to 0.31) | −1.05 (−1.46 to −0.63) | −1.18 (−1.61 to −0.76) | |||||||
|
BAIf | 0.91 (0.64 to 1.18) | 0.63 (0.38 to 0.87) | 0.02 (−0.12 to 0.15) | 0.05 (−0.39 to 0.49) | −0.68 (−1.10 to − 0.26) | −0.63 (−1.07 to −0.20) | |||||||
|
Positive Affect subscale of the Positive and Negative Affect Schedule | −1.27 (−1.58 to −0.95) | −0.69 (−0.92 to −0.45) | −0.01 (−0.22 to 0.20) | −0.25 (−0.66 to 0.17) | 0.90 (0.49 to 1.31) | 0.74 (0.33 to 1.15) | |||||||
|
Negative Affect subscale of the Positive and Negative Affect Schedule | 1.26 (0.94 to 1.57) | 1.28 (0.96 to 1.60) | −0.04 (−0.22 to 0.14) | −0.01 (−0.42 to 0.40) | −0.91(−1.32 to −0.50) | −0.99 (−1.41 to −0.57) | |||||||
Secondary outcomes | ||||||||||||||
|
Personality measures | |||||||||||||
|
|
Neuroticism subscale of the NEO FFIg | 0.78 (0.51 to 1.05) | 0.73 (0.50 to 0.96) | 0.04 (−0.22 to 0.20) | −0.12 (−0.54 to 0.29) | −0.47 (−0.87 to −0.08) | 0.61 (−1.01 to −0.21) | ||||||
|
|
Extraversion subscale of the NEO FFI | 0.65 (−0.88 to −0.42) | 0.30 (−0.45 to −0.14) | 0.22 (0.07 to 0.37) | −0.01 (−0.42 to 0.40) | 0.48 (0.08 to 0.88) | 0.46 (0.06 to 0.86) | ||||||
|
Quality of life | |||||||||||||
|
|
EuroQoL-5D-3L questionnaire | 0.70 (−0.97 to −0.43) | 0.53 (−0.80 to −0.25) | 0.04 (−0.21 to 0.14) | −0.25 (−0.70 to 0.19) | 0.86 (0.44 to 1.29) | 0.60 (0.17 to 1.04) |
aTIBP+PA: transdiagnostic internet-based protocol+positive affect component.
bTIBP: transdiagnostic internet-based protocol.
cWL: waiting list.
dPost-T: posttreatment.
eBDI-II: Beck Depression Inventory-II.
fBAI: Beck Anxiety Inventory.
gNEO FFI: NEO Five Factor Inventory.